Oncology · 2 h ago
ANO6-dependent CAF trogocytosis supports pancreatic cancer growth and immune suppression
A Nature Cancer study reports that pancreatic cancer-associated fibroblasts transfer cholesterol and other membrane lipids to pancreatic ductal adenocarcinoma (PDAC) cells through ANO6-dependent trogocytosis. In preclinical models, blocking ANO6 reduced tumor growth and attenuated fibroblast-mediated suppression of cytotoxic T cells.
- CAFs transferred LDL-derived lipids to PDAC cells through membrane trogocytosis.
- ANO6 activity supported lipid transfer and CAF-mediated T-cell suppression.
- ANО6 blockade reduced tumor growth in preclinical models.
- Clinical efficacy and safety have not been established.
The study examined how PDAC cells acquire lipids in a tumor environment with few functional blood vessels. In mouse PDAC models, researchers tracked fluorescent, blood-borne LDL and observed its initial uptake by cancer-associated fibroblasts (CAFs), followed by transfer toward cancer cells. Experiments using labeled CAFs and PDAC cells also supported contact-dependent transfer of CAF membrane material.
The authors report that calcium influx through Orai channels activates ANO6 in CAFs, promoting phosphatidylserine exposure and membrane trogocytosis. This process transferred cholesterol and other membrane lipids to PDAC cells and supported their survival. CAF membrane trogocytosis by cytotoxic T cells was also linked to immune suppression. ANO6 blockade reduced tumor growth, partly by disrupting cholesterol delivery, and attenuated this immune-suppressive effect.
The findings identify ANO6 as a candidate target for further investigation in PDAC. The evidence described is preclinical and does not establish safety or efficacy in patients; the source provides no clinical trial results or patient outcomes.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Nature Cancer: ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.